Cargando…

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

BACKGROUND: Simeprevir is a N3/4 protease inhibitor approved for the treatment of hepatitis C virus (HCV) infection. HCV prevalence is higher in patients with chronic kidney disease compared with the general population; safe and efficacious therapies in renal impairment are needed. OBJECTIVES: To ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouwerkerk-Mahadevan, Sivi, Beumont-Mauviel, Maria, Mortier, Steven, Peeters, Monika, Verloes, Rene, Truyers, Carla, Mannens, Geert, Wynant, Inneke, Simion, Alexandru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561054/ https://www.ncbi.nlm.nih.gov/pubmed/26248593 http://dx.doi.org/10.1007/s40268-015-0101-0

Ejemplares similares

Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
por: Ouwerkerk-Mahadevan, Sivi, et al.
Publicado: (2015)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications
por: Marra, Fiona, et al.
Publicado: (2018)

Population Pharmacokinetic Analysis of Bedaquiline‐Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study
por: Kurosawa, Ken, et al.
Publicado: (2021)

Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
por: He, Ping, et al.
Publicado: (2014)

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
por: Bourgeois, Stefan, et al.
Publicado: (2017)

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
por: Vijgen, Leen, et al.
Publicado: (2017)

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
por: Scott, Jane, et al.
Publicado: (2014)

Pharmacokinetics, safety, and tolerability of the 2‐ and 3‐direct‐acting antiviral combination of AL‐335, odalasvir, and simeprevir in healthy subjects
por: Kakuda, Thomas N., et al.
Publicado: (2018)

The Modern Theory of Renal Excretion
Publicado: (1919)

THE TUBULAR FACTOR IN RENAL HEMOGLOBIN EXCRETION
por: Yuile, Charles L., et al.
Publicado: (1941)

The Influence of Disease on the Renal Excretion of Water
por: Welt, Louis G.
Publicado: (1956)

Simeprevir for the treatment of hepatitis C virus infection
por: Izquierdo, Laure, et al.
Publicado: (2014)

In vitro susceptibility of human Blastocystis subtypes to simeprevir
por: Mossallam, Shereen F., et al.
Publicado: (2021)

Simeprevir restores the anti-Staphylococcus activity of polymyxins
por: Wu, Yuan, et al.
Publicado: (2023)

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study
por: Lawitz, Eric, et al.
Publicado: (2020)

Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B
por: Nakayama, Shinji, et al.
Publicado: (2023)

THE EFFECT OF SEX HORMONES ON THE RENAL EXCRETION OF ELECTROLYTES
por: Thorn, George W., et al.
Publicado: (1938)

Vasopressin regulates renal calcium excretion in humans
por: Hanouna, Guillaume, et al.
Publicado: (2015)

Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma
por: El Sharkasy, Mona E., et al.
Publicado: (2022)

Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil
por: Han, Seung Yon, et al.
Publicado: (2020)

The Pharmacokinetics of The Biliary Excretion of Ciprofloxacin
por: Ball, C. S., et al.
Publicado: (1989)

Pharmacokinetics of Cabotegravir in Subjects with Severe Renal Impairment
por: Parasrampuria, Ridhi, et al.
Publicado: (2017)

THE RENAL MECHANISM FOR URATE EXCRETION IN THE DALMATIAN COACH-HOUND
por: Wolfson, William Q., et al.
Publicado: (1950)

THE EFFECT OF CORTICOSTERONE AND RELATED COMPOUNDS ON THE RENAL EXCRETION OF ELECTROLYTES
por: Thorn, George W., et al.
Publicado: (1938)

Renal Excretion of Sodium and the Concept of a Volume Receptor
por: Epstein, Franklin H.
Publicado: (1956)

Potential and Limits of Kidney Cells for Evaluation of Renal Excretion
por: Lechner, Christian, et al.
Publicado: (2021)

The relationship between renal function and renal urodilatin excretion immediately after cardiac surgery
por: Heringlake, M, et al.
Publicado: (2001)

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study
por: Gane, Edward J., et al.
Publicado: (2017)

Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets
por: Wang, Wenxiang, et al.
Publicado: (2022)

Effect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure
por: Lemos, C.C.S., et al.
Publicado: (2013)

Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function
por: Hoover, Randall K., et al.
Publicado: (2017)

Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
por: Berg, Jolene K., et al.
Publicado: (2018)

A proteolytic modification of AIM promotes its renal excretion
por: Yamazaki, Tomoko, et al.
Publicado: (2016)

Completing the Enalaprilat Excretion Pathway—Renal Handling by the Proximal Tubule
por: Smeets, Nori J. L., et al.
Publicado: (2020)

Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide
por: Li, Daniel Y., et al.
Publicado: (2021)

Modelling the Renal Excretion of the Mycotoxin Deoxynivalenol in Humans in an Everyday Situation
por: van den Brand, Annick D., et al.
Publicado: (2021)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C
por: Sarkar, Souvik, et al.
Publicado: (2015)

A simeprevir-inducible molecular switch for the control of cell and gene therapies
por: Chin, Stacey E., et al.
Publicado: (2023)

Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
por: Stark, Jeffrey G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bnon5oh1vs49glgo0fk8j8mvo8